(Q35584511)

9 August 2017

title

Chemotherapy-related hospitalization among community cancer center patients (English)

1 reference

9 August 2017

1 reference

1 reference

Michael J Hassett

1

1 reference

9 August 2017

Sowmya R Rao

2

1 reference

9 August 2017

Suzana Brozovic

3

1 reference

9 August 2017

James E Stahl

4

1 reference

9 August 2017

Joel H Schwartz

5

1 reference

9 August 2017

Betty Maloney

6

1 reference

9 August 2017

Joseph O Jacobson

7

1 reference

9 August 2017

publication date

24 February 2011

1 reference

9 August 2017

1 reference

9 August 2017

volume

16

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

378-387

1 reference

Development of a patient registry to evaluate hospital admissions related to chemotherapy toxicity in a community cancer center

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Measuring supportive care in medical oncology practice: lessons learned from the quality oncology practice initiative

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Factors influencing inclusion of patients with malignancies in clinical trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

A process for measuring the quality of cancer care: the Quality Oncology Practice Initiative

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Systematic review to determine whether participation in a trial influences outcome

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Never too old? Age should not be a barrier to enrollment in cancer clinical trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

The impact of socioeconomic status and race on trial participation for older women with breast cancer.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Adverse drug reactions: definitions, diagnosis, and management

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Measuring comorbidity in older cancer patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Threats to applicability of randomised trials: exclusions and selective participation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Exclusion of elderly people from clinical research: a descriptive study of published reports

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Toxicity and response criteria of the Eastern Cooperative Oncology Group

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Implementation of the Quality Oncology Practice Initiative at a university comprehensive cancer center

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Improvement in oncology practice performance through voluntary participation in the Quality Oncology Practice Initiative

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Enrollment of African Americans onto clinical treatment trials: study design barriers

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228109

Participation in cancer clinical trials: race-, sex-, and age-based disparities

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21349949

12 December 2020

inferred from PubMed ID database lookup

Dissemination of Information on Potentially Fatal Adverse Drug Reactions for Cancer Drugs From 2000 to 2002: First Results From the Research on Adverse Drug Events and Reports Project

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21349949

12 December 2020

inferred from PubMed ID database lookup

Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21349949

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1634/THEONCOLOGIST.2010-0354

1 reference

release_c3mvw3awifbsxmcgs2ak5bkxhm

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/c3mvw3awifbsxmcgs2ak5bkxhm

24 November 2022

mapped directly with Wikidata item

PMC publication ID

3228109

1 reference

9 August 2017

1 reference